The announcement won't come from the FDA. I expect USRM will decide on timing of release post approval. Hopefully sooner than later. USRM is positioned to pounce on the opportunity post RMAT designation.
Been holding for a long time. Getting a little tired of waiting. Patience should be rewarded with this one though imo.
Market Data 
Markets 
AI
